Literature DB >> 33553423

Overexpression of Limb Bud and Heart Alleviates Sepsis-Induced Acute Lung Injury via Inhibiting the NLRP3 Inflammasome.

Yifan Wang1, Yang Shi1, Xiaohong Zhang1, Jing Fu1, Feng Chen1.   

Abstract

OBJECTIVE: Sepsis is a leading cause of acute lung injury (ALI). This study attempted to investigate the effects of limb bud and heart (LBH) on the development of sepsis-induced ALI and its underlying mechanism of action.
METHODS: The sepsis-induced ALI mouse model was established by cecal ligation and puncture (CLP). The lung injury score and lung wet/dry weight (W/D) ratio were used to evaluate the lung injury. In vitro, ALI was simulated by lipopolysaccharide (LPS) treatment in A549 cells. The mRNA expression of LBH, NLRP3, ASC, and proinflammatory cytokines was measured by qRT-PCR. The viability of LPS-induced A549 cells was analyzed by MTT assay. Furthermore, western blot was performed to detect the protein expression of LBH, NLRP3, and ASC. LPS-induced A549 cells were treated with MCC950 (NLRP3 inflammasome inhibitor) to confirm the effect of LBH on NLRP3 inflammasome.
RESULTS: The mRNA and protein expression of LBH was decreased in sepsis-induced ALI. LBH overexpression reduced the lung injury score, lung W/D ratio, expression of proinflammatory cytokines, and NLRP3 inflammasome activation in sepsis-induced ALI mouse model. Additionally, LBH upregulation increased the viability, while it decreased the proinflammatory cytokine expression and NLRP3 inflammasome activation of LPS-induced A549 cells. Moreover, MCC950 reversed the promoting effects of LBH silencing on proinflammatory cytokine expression and NLRP3 inflammasome activation in LPS-induced A549 cells.
CONCLUSIONS: LBH alleviated lung injury in sepsis-induced ALI mouse model by inhibiting inflammation and NLRP3 inflammasome, and restrained the inflammation by inhibiting NLRP3 inflammasome in LPS-induced A549 cells, providing a novel therapeutic target for ALI.
Copyright © 2021 Yifan Wang et al.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33553423      PMCID: PMC7847343          DOI: 10.1155/2021/4084371

Source DB:  PubMed          Journal:  Biomed Res Int            Impact factor:   3.411


  50 in total

Review 1.  Molecular mechanisms regulating NLRP3 inflammasome activation.

Authors:  Eun-Kyeong Jo; Jin Kyung Kim; Dong-Min Shin; Chihiro Sasakawa
Journal:  Cell Mol Immunol       Date:  2015-11-09       Impact factor: 11.530

2.  The NLRP3 inflammasome promotes renal inflammation and contributes to CKD.

Authors:  Akosua Vilaysane; Justin Chun; Mark E Seamone; Wenjie Wang; Rick Chin; Simon Hirota; Yan Li; Sharon A Clark; Jurg Tschopp; Kiril Trpkov; Brenda R Hemmelgarn; Paul L Beck; Daniel A Muruve
Journal:  J Am Soc Nephrol       Date:  2010-08-05       Impact factor: 10.121

3.  Downregulated expression of LBH mRNA in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.

Authors:  Yan Chang; Yujun Sheng; Yuyan Cheng; Yan Lin; Zhengwei Zhu; Leilei Wen; Chao Yang; Lulu Yang; Lu Liu; Fusheng Zhou; Xiaodong Zheng; Shengquan Zhang; Yong Cui; Sen Yang; Xuejun Zhang
Journal:  J Dermatol       Date:  2015-06-30       Impact factor: 4.005

Review 4.  Mechanism and Regulation of NLRP3 Inflammasome Activation.

Authors:  Yuan He; Hideki Hara; Gabriel Núñez
Journal:  Trends Biochem Sci       Date:  2016-09-23       Impact factor: 13.807

Review 5.  Acute lung injury and the acute respiratory distress syndrome: a clinical review.

Authors:  Arthur P Wheeler; Gordon R Bernard
Journal:  Lancet       Date:  2007-05-05       Impact factor: 79.321

6.  Infection site is predictive of outcome in acute lung injury associated with severe sepsis and septic shock.

Authors:  Seitaro Fujishima; Satoshi Gando; Saitoh Daizoh; Shigeki Kushimoto; Hiroshi Ogura; Toshihiko Mayumi; Kiyotsugu Takuma; Joji Kotani; Norio Yamashita; Ryosuke Tsuruta; Naoshi Takeyama; Shin-Ichiro Shiraishi; Tsunetoshi Araki; Koichiro Suzuki; Hiroto Ikeda; Yasuo Miki; Yasushi Suzuki; Yoshihiro Yamaguchi; Naoki Aikawa
Journal:  Respirology       Date:  2016-03-30       Impact factor: 6.424

7.  Maresin 1 mitigates LPS-induced acute lung injury in mice.

Authors:  Jie Gong; Zhou-yang Wu; Hong Qi; Lin Chen; Hong-bin Li; Bo Li; Cheng-ye Yao; Ya-xin Wang; Jing Wu; Shi-ying Yuan; Shang-long Yao; You Shang
Journal:  Br J Pharmacol       Date:  2014-07       Impact factor: 8.739

8.  The role of the NLRP3 inflammasome in gout.

Authors:  Sarah R Kingsbury; Philip G Conaghan; Michael F McDermott
Journal:  J Inflamm Res       Date:  2011-03-13

9.  Limb-bud and Heart (LBH) functions as a tumor suppressor of nasopharyngeal carcinoma by inducing G1/S cell cycle arrest.

Authors:  Qicai Liu; Xiaoying Guan; Jingli Lv; Xiaoyan Li; Yingfeng Wang; Li Li
Journal:  Sci Rep       Date:  2015-01-05       Impact factor: 4.379

10.  LncRNA TUG1 alleviates sepsis-induced acute lung injury by targeting miR-34b-5p/GAB1.

Authors:  Nan Qiu; Xinmei Xu; Yingying He
Journal:  BMC Pulm Med       Date:  2020-02-22       Impact factor: 3.317

View more
  1 in total

1.  Glycyrrhizic Acid Protects Experimental Sepsis Rats against Acute Lung Injury and Inflammation.

Authors:  Jiali Shen; Zhongjie Hua; Yueyang Chai
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-29       Impact factor: 2.650

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.